Novartis to Acquire Avidity Biosciences Novartis will buy Avidity Biosciences for US$12 billion, gaining its RNA-based therapeutic platform and rare-disease programmes. The transact…
ASX Winners and Losers of Today The table ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each…
African Tax Leaders Meet to Tackle Effective Taxation The taxation of the wealthy is a key challenge for tax professionals and policymaker…
Nearly 2,000 People Attend Community Event Nearly 2,000 people attended Godmanchester's Apple Day at the Community Plant Nursery on Octobe…
Herefordshire Couple Denied Solar Panels on Historic Farmhouse A government planning inspector has rejected a Herefordshire couple's appli…
Nordic Capital Acquires BMLL to Boost Financial Data Transparency IBS Intelligence, a leading financial technology research and advisory f…
Making Children with Speech Disorders Comfortable on Halloween For children with speech or language disorders, saying "trick or treat" on …
Social Security in 2026: Experts Weigh in on Plans Social Security has had a significant impact, lifting 22 million Americans out of pover…
GSK Secures Rights to Syndivia's ADC Asset for Prostate Cancer GSK acquires exclusive rights from Syndivia for an ADC targeting advanced p…
EU Warns Israel of Sanctions Over West Bank Annexation The European Union has warned Israel of potential sanctions if it proceeds with the…
Cisco and G42 Deepen US-UAE Technology Partnership Cisco and G42 are expanding their collaboration to advance secure AI infrastructure in …